BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BlueRock Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11117
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BlueRock Therapeutics is a biotechnology company that develops novel stem cell therapies to treat cardiovascular and neurodegenerative diseases. The company’s therapeutic candidate is used to treat Parkinson’s disease that restores dopamine production in the midbrain by retaining dopamine-secreting cells which are affected due to degenerative disease conditions. It also develops cardiomyocytes which are lost during the heart attack in an infarcted heart to remuscularize the heart. BlueRock Therapeutics’ therapeutic platform is based on induced pluripotent stem cells which can be generated from cells in a normal blood draw from a consenting adult and produced using cell manufacturing technologies. The company has operations in Canada and the US. BlueRock Therapeutics is headquartered in Toronto, Ontario, Canada.

BlueRock Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
Partnerships 11
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
Licensing Agreements 12
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
Equity Offering 14
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics – Key Competitors 15
BlueRock Therapeutics – Key Employees 16
BlueRock Therapeutics – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Oct 26, 2017: BlueRock Therapeutics Establishes Corporate Headquarters in Cambridge, Massachusetts and Bolsters Team to Support Rapid Growth and Development 18
Aug 17, 2017: BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership 19
Corporate Communications 20
Sep 20, 2018: BlueRock Therapeutics names Shane Kovacs as chief business and financial officer 20
Dec 01, 2017: BlueRock Therapeutics Announces Appointment of Derek Hei, Ph.D. as Senior VP, Manufacturing, Quality and Regulatory 21
Jun 27, 2017: BlueRock Therapeutics Announces Key Members of Executive Team 22
Government and Public Interest 23
Jan 05, 2018: Get to Know the Revolutionary Medical Innovations Being Unleashed in Canada 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics, Key Competitors 15
BlueRock Therapeutics, Key Employees 16
BlueRock Therapeutics, Other Locations 17

List of Figures
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Best Doctors Inc-製薬・医療分野:企業M&A・提携分析
    Summary Best Doctors Inc (Best Doctors) is a healthcare service provider that offers medical services. The company provides services such as inter-consultation and critical care inter-consultation services for multi-trauma, spinal cord injuries, traumatic brain injuries, severe burns, and sepsis. It …
  • Escalon Medical Corp (ESMC):企業の財務・戦略的SWOT分析
    Escalon Medical Corp (ESMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tox Free Solutions Limited (TOX):企業の財務・戦略的SWOT分析
    Tox Free Solutions Limited (TOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hoteli Maestral d.d.:企業の戦略・SWOT・財務情報
    Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Misen Energy AB (MISE):企業の財務・戦略的SWOT分析
    Summary Misen Energy AB (Misen), formerly Svenska Capital Oil AB is an oil and gas company that provides pipeline services. The company offers production of gas and oil fields by implementation of large-scale investment programs and introduction of modern western knowhow and technology. It offers de …
  • Ithaca Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Ithaca Energy Inc. (Ithaca), a subsidiary of Delek Group Ltd., is an oil and gas company, which explores for, develops, and produces oil and gas in the North Sea. It focuses on the appraisal and development of undeveloped discoveries and the exploitation of its existing UK producing asset po …
  • Accugenomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • BioDelivery Sciences International Inc (BDSI)-製薬・医療分野:企業M&A・提携分析
    Summary BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; bupren …
  • OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析
    OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kalgene Pharmaceuticals Inc (Kalgene Pharmaceuticals) is a pre-clinical stage biotechnology company focused on the development of novel fusion protein therapeutic's for the treatment of neurodegenerative diseases. Its lead product candidate KAL-ABP, targets toxic amyloid beta oligomers that …
  • New Brunswick Power Corporation:企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Venture Global LNG Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Venture Global LNG Inc (VGLI) is an exporter of american-produced liquefied natural gas. The company owns and manages two Louisiana-based export projects Calcasieu Pass and Plaquemines. The company through subsidiary Venture Global Calcasieu Pass, LLC, operates Calcasieu Pass project, which …
  • Ward Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Ward Petroleum Corp (Ward Petroleum) is an independent oil and gas exploration and production company. The company acquires, explores, develops and produces natural gas and petroleum resources. It drills horizontal wells in Garfield County, Oklahoma and Anadarko Basin in Mid-Continent region …
  • Alabama Power Co:企業の戦略的SWOT分析
    Alabama Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Varian Medical Systems Inc (VAR):医療機器:M&Aディール及び事業提携情報
    Summary Varian Medical Systems Inc (VMS) designs, manufactures and sells medical devices and software for the treatment of cancer and other medical conditions through radiotherapy, proton therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. The company’s major produ …
  • HomeServe plc (HSV):企業の財務・戦略的SWOT分析
    HomeServe plc (HSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Singing Machine Company, Inc.:戦略・SWOT・企業財務分析
    The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mitsubishi Paper Mills Ltd (38640):企業の財務・戦略的SWOT分析
    Mitsubishi Paper Mills Ltd (38640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Siemens AG (SIE):電力:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆